JP2022163194A5 - - Google Patents

Download PDF

Info

Publication number
JP2022163194A5
JP2022163194A5 JP2022129624A JP2022129624A JP2022163194A5 JP 2022163194 A5 JP2022163194 A5 JP 2022163194A5 JP 2022129624 A JP2022129624 A JP 2022129624A JP 2022129624 A JP2022129624 A JP 2022129624A JP 2022163194 A5 JP2022163194 A5 JP 2022163194A5
Authority
JP
Japan
Prior art keywords
conjugate
daltons
seq
ethylene glycol
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022129624A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022163194A (ja
Filing date
Publication date
Priority claimed from JP2017547157A external-priority patent/JP2018510863A/ja
Application filed filed Critical
Publication of JP2022163194A publication Critical patent/JP2022163194A/ja
Publication of JP2022163194A5 publication Critical patent/JP2022163194A5/ja
Pending legal-status Critical Current

Links

JP2022129624A 2015-03-11 2022-08-16 Il-7部分とポリマーとのコンジュゲート Pending JP2022163194A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562131634P 2015-03-11 2015-03-11
US62/131,634 2015-03-11
JP2017547157A JP2018510863A (ja) 2015-03-11 2016-03-11 Il−7部分とポリマーとのコンジュゲート
PCT/US2016/022146 WO2016145388A1 (en) 2015-03-11 2016-03-11 Conjugates of an il-7 moiety and an polymer

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2017547157A Division JP2018510863A (ja) 2015-03-11 2016-03-11 Il−7部分とポリマーとのコンジュゲート

Publications (2)

Publication Number Publication Date
JP2022163194A JP2022163194A (ja) 2022-10-25
JP2022163194A5 true JP2022163194A5 (https=) 2023-01-04

Family

ID=56878892

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017547157A Withdrawn JP2018510863A (ja) 2015-03-11 2016-03-11 Il−7部分とポリマーとのコンジュゲート
JP2021031726A Pending JP2021091708A (ja) 2015-03-11 2021-03-01 Il−7部分とポリマーとのコンジュゲート
JP2022129624A Pending JP2022163194A (ja) 2015-03-11 2022-08-16 Il-7部分とポリマーとのコンジュゲート

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2017547157A Withdrawn JP2018510863A (ja) 2015-03-11 2016-03-11 Il−7部分とポリマーとのコンジュゲート
JP2021031726A Pending JP2021091708A (ja) 2015-03-11 2021-03-01 Il−7部分とポリマーとのコンジュゲート

Country Status (11)

Country Link
US (1) US20190290733A1 (https=)
EP (1) EP3285799A4 (https=)
JP (3) JP2018510863A (https=)
KR (2) KR20170125839A (https=)
CN (1) CN107405384A (https=)
AU (1) AU2016228555B2 (https=)
CA (1) CA2978330C (https=)
IL (1) IL254389B2 (https=)
MA (1) MA41957A (https=)
MX (1) MX391071B (https=)
WO (1) WO2016145388A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7052686B2 (en) 2000-09-29 2006-05-30 Schering Corporation Pegylated interleukin-10
CA2664304C (en) 2006-09-28 2017-08-22 Schering Corporation Use of pegylated il-10 to treat cancer
EP2986306A4 (en) 2013-04-18 2016-12-07 Armo Biosciences Inc METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING
ES2688206T3 (es) 2013-06-17 2018-10-31 Armo Biosciences, Inc. Procedimiento de evaluación de la identidad y la estabilidad de proteínas
EP3068425B1 (en) 2013-11-11 2021-01-27 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US10618970B2 (en) 2015-02-03 2020-04-14 Armo Biosciences, Inc. Method of treating cancer with IL-10 and antibodies that induce ADCC
CA2986755A1 (en) 2015-05-28 2016-12-01 Armo Biosciences, Inc. Pegylated interleukin-10 for use in treating cancer
US10398761B2 (en) 2015-08-25 2019-09-03 Armo Biosciences, Inc. Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers
WO2020121071A1 (en) * 2018-12-12 2020-06-18 Levim Biotech Llp Acylation process for preparation of n-substituted peptide
WO2022020637A1 (en) * 2020-07-22 2022-01-27 Nektar Therapeutics Il-7 receptor agonist composition and related methods and uses
WO2023133595A2 (en) 2022-01-10 2023-07-13 Sana Biotechnology, Inc. Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
US20250222027A1 (en) 2022-04-01 2025-07-10 Sana Biotechnology, Inc. Cytokine receptor agonist and viral vector combination therapies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666400B2 (en) * 2005-04-06 2010-02-23 Ibc Pharmaceuticals, Inc. PEGylation by the dock and lock (DNL) technique
AU2002307497A1 (en) * 2001-04-23 2002-11-05 The Regents Of The University Of California Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
AP2004003050A0 (en) * 2001-11-20 2004-06-30 Pharmacia Corp Chemically modified human growth hormone conjugates
EP1391513A1 (en) * 2002-08-08 2004-02-25 Cytheris IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof
NZ541122A (en) * 2002-12-26 2008-09-26 Mountain View Pharmaceuticals Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof with preserved receptor-binding activity
CN101072793B (zh) * 2004-12-09 2012-06-20 默克专利有限公司 具有降低的免疫原性的il-7变体
CA2711503A1 (en) * 2008-01-08 2009-07-16 Biogenerix Ag Glycoconjugation of polypeptides using oligosaccharyltransferases
ES2866674T3 (es) * 2010-11-12 2021-10-19 Nektar Therapeutics Conjugados de una fracción de IL-2 y un polímero
CN102145178B (zh) * 2011-04-15 2012-09-26 北京凯因科技股份有限公司 Peg化白介素15
WO2013020079A2 (en) * 2011-08-04 2013-02-07 Nektar Therapeutics Conjugates of an il-11 moiety and a polymer
US9375465B2 (en) * 2011-11-14 2016-06-28 Emory University Conjugates of GM-CSF and IL-7, compositions and methods related thereto

Similar Documents

Publication Publication Date Title
JP2022163194A5 (https=)
CN1134265C (zh) 用作为免疫佐剂的磷腈聚电解质
JP2004520473A5 (https=)
CN115197079A (zh) 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用
TW585772B (en) Pharmaceutical composition for reducing oxalate levels in a patient
CN116003787B (zh) 含疏水烷基链的高度支化聚(β-氨基酯)及其制备方法和mRNA递送应用
JP2006520323A5 (https=)
JP2012502990A5 (https=)
JP2018510863A5 (https=)
JP2009501127A5 (https=)
US20120237470A1 (en) Amido-amine polymer compositions
CN1245425A (zh) 聚(二烯丙基胺)基胆汁酸多价螯合体
RU2007127993A (ru) Сахарид-конъюгатные вакцины
JP2010512792A5 (https=)
AU600460B2 (en) Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses
CH675728A5 (https=)
CN115515926A (zh) 一种聚乙二醇化脂质及其修饰的脂质体、含该脂质体的药物组合物及其制剂和应用
CN101481415A (zh) 一种新型prrs病毒受体及该受体的阻断抑制剂
JPWO2021140416A5 (https=)
CN102464801B (zh) 一种阳离子聚合物及其制备方法和用途
US20100166696A1 (en) Amido-amine dendrimer compositions
JP2008518953A5 (https=)
CN1464789B (zh) 抗流感病毒疫苗及所述病毒疫苗的制备方法
CA2602654A1 (en) Method for shielding functional sites or epitopes on proteins
CN111655758B (zh) 核酸投递用聚合物